Marinus (MRNS) - P/E multiplikatori

Marinus Pharma - MRNS emitenti grafik logotipi

Marinus Pharmaceuticals (MRNS) uchun bozor tendentsiyasi -0.20 qiymatini namoyish etib, epilepsiya terapiyasi ishlab chiquvchisining bozor mavqeini tasdiqlamoqda. Formulalar uchun patent himoyasi va neyrosteroid sintezining murakkabligi arzon generik dori vositalarining kirishini to'sadi. Biznes daromadlari ganaxolonega bo'lgan talab va uning qo'llanilishining kengayishiga asoslangan. Biroq, xalqaro mojarolar va sanksiyalar biomateriallar logistikasiga to'sqinlik qilmoqda, bu esa yangi mahsulotlarning sertifikatsiyasini murakkablashtirmoqda.

Marinus Pharmaceuticals, Inc. (MRNS) - P/E multiplikatori 04.07.2022dan 22.02.2025gacha

Marinus Pharma (MRNS) kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Marinus Pharmaceuticals
Marinus tovar namunasi

P/E koeffitsiyenti Marinus Pharmaceuticals (MRNS) bozor qiymati va uning sof foydasi o'rtasidagi bog'liqlikni aks ettiradi. Ushbu koeffitsient haqiqiy pul oqimlari orqali investitsiyalarning qoplanish muddatini belgilaydi. Kompaniyaning P/E diapazonini tahlil qilish orqali investor aktivlarning uning rentabelligiga nisbatan qanchalik qimmat baholanganlik darajasini aniqlaydi. Multiplikator dinamikasi epilepsiya davolash dori vositalarining sotuv hajmlariga bevosita bog'liq. Ushbu metrikaning barqarorligi sug'urta qamrovining samaradorligini va innovatsion dori vositalarining shifoxonalar tomonidan xarid qilinishini tasdiqlaydi.

Raqobatdosh kompaniyalar

Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalizatsiyaning sof foydaga nisbati|anavex.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell, Inc.)|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon Biosciences Inc.) - P/E multiplikatori|omeros.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurogene (NGNE)|Biznesning o‘zini qoplash muddati AC Immune SA|P/E multiplikatori VYGR (voyagertherapeutics.com)|P/E multiplikatori Neumora NMRA|Scilex Holding - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Narxning foydaga nisbati|cogrx.com (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Assertio Therapeutics (ASRT)|Biznesning o‘zini qoplash muddati Coya|Vistagen - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OVID|Acumen Pharmaceuticals Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CervoMed Inc|ATHE: P/E multiplikatori|Narx-foyda koeffitsiyenti Clene Nanomedicine|Narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalizatsiyaning foydaga nisbati|gracetx.com - Narx-foyda koeffitsiyenti|AIFF: Narx-foyda multiplikatori|Klotho Neurosciences - P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narx-foyda multiplikatori|Reviva Pharmaceuticals (RVPH) - Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narxning foydaga nisbati|Narxning foydaga nisbati NeurAxis, Inc|Narxning foydaga nisbati HSDT|P/E multiplikatori PASG|Biznesning o‘zini qoplash muddati Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Narx-foyda koeffitsiyenti|P/E multiplikatori Athira ATHA|Addex Therapeutics - P/E multiplikatori|ALZN - P/E multiplikatori|Cyclerion (CYCN) - Narxning foydaga nisbati|Protagenic (PTIX) - P/E multiplikatori|Narxning foydaga nisbati Pasithea|Narx-foyda multiplikatori CRGT (Cortigent)|Narxning foydaga nisbati Avenue Therapeutics (ATXI)|BCLI - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori CARA (Cara Therapeutics Inc)|CHRO - Narx-foyda koeffitsiyenti|ELYM: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori